ALKEM Laboratories has announced that a meeting of the Board of Directors is scheduled for November 13th, 2025. The board will consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended September 30th, 2025. This meeting will provide insights into the company’s financial performance for Q2 FY26.
Board Meeting Announcement
The Board of Directors of ALKEM Laboratories is scheduled to convene on Thursday, November 13th, 2025.
Agenda: Financial Results
The primary focus of the meeting will be to review and approve the Standalone and Consolidated Unaudited Financial Results. These results pertain to the quarter and half year which concluded on September 30th, 2025 (Q2 FY26).
Source: BSE
